ZA959417B - Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence - Google Patents

Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence

Info

Publication number
ZA959417B
ZA959417B ZA959417A ZA959417A ZA959417B ZA 959417 B ZA959417 B ZA 959417B ZA 959417 A ZA959417 A ZA 959417A ZA 959417 A ZA959417 A ZA 959417A ZA 959417 B ZA959417 B ZA 959417B
Authority
ZA
South Africa
Prior art keywords
peptides
analogues
production
dna sequence
corresponding dna
Prior art date
Application number
ZA959417A
Other languages
English (en)
Inventor
Hans Binz
Thien Nguyen Ngoc
Stefan Stahl
Mathias Uhlen
Per Ake Nygren
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of ZA959417B publication Critical patent/ZA959417B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA959417A 1994-11-07 1995-11-07 Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence ZA959417B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413307A FR2726576B1 (fr) 1994-11-07 1994-11-07 Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante

Publications (1)

Publication Number Publication Date
ZA959417B true ZA959417B (en) 1996-06-11

Family

ID=9468565

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959417A ZA959417B (en) 1994-11-07 1995-11-07 Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence

Country Status (8)

Country Link
EP (1) EP0791059A1 (xx)
JP (1) JPH10508479A (xx)
AU (1) AU704594B2 (xx)
CA (1) CA2204511A1 (xx)
FR (1) FR2726576B1 (xx)
NZ (1) NZ296562A (xx)
WO (1) WO1996014409A1 (xx)
ZA (1) ZA959417B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789653A (en) * 1995-01-10 1998-08-04 University Of Edinburgh Secretory gene trap
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
AUPO026596A0 (en) * 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
FR2819810B1 (fr) * 2001-01-23 2004-05-28 Pf Medicament Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
ES2500918T3 (es) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Proteínas de fusión de albúmina e interferón beta
JP6744225B2 (ja) * 2014-02-14 2020-08-19 シンヴィヴォ コーポレイション ハイブリッドタンパクおよびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605476B2 (en) * 1986-01-14 1991-01-17 University Of North Carolina, The Vaccines for human respiratory virus
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
AU7410987A (en) * 1986-06-12 1988-01-07 Immunex Corp. Polypeptides devoid of hydrophobic amino acids
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
EP0452364B1 (en) * 1988-12-22 2002-05-22 Genentech, Inc. Method for preparing water soluble polypeptides

Also Published As

Publication number Publication date
FR2726576A1 (fr) 1996-05-10
JPH10508479A (ja) 1998-08-25
EP0791059A1 (fr) 1997-08-27
FR2726576B1 (fr) 1997-01-31
AU704594B2 (en) 1999-04-29
WO1996014409A1 (fr) 1996-05-17
NZ296562A (en) 1999-11-29
AU4120096A (en) 1996-05-31
CA2204511A1 (fr) 1996-05-17

Similar Documents

Publication Publication Date Title
IL146093A0 (en) Method of separating a polypeptide or protein from a solution containing a plurality thereof
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
IL121520A (en) Polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive or a fragment or truncation thereof
EP2327775A3 (en) Therapy for alpha-galactosidase a deficiency
DE4393381T1 (de) Peptide
DE69332485D1 (de) Immunmodulierende peptide
EP1619202A3 (en) immunotherapeutic methods using epitopes of wt-1 and gata-1
HUP9802372A3 (en) Cyclic peptide analogs of somatostatin
AU4415796A (en) Production of c-terminal amidated peptides from recombinant protein constructs
GB9126329D0 (en) Opioid peptides derived from wheat proteins
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
ZA959417B (en) Production of peptides which are analogues of hydrophobic peptides recombinant peptide corresponding DNA sequence
HUP9903961A3 (en) Tripeptide intermediates of antithrombotic azacycloalkylalkanoyl peptides
IL116973A0 (en) Extraction of recombinant proteins
GB9714680D0 (en) Recombinant production of proteins
IL122412A0 (en) Recombinant viral nucleic acids
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
GB2336844B (en) Anti-hiv peptides and proteins
GB9714681D0 (en) Recombinant production of proteins
EP0744467A3 (en) Multi-antigenic peptide comprising at least two peptides associated with the hepatitis C virus
AU4410689A (en) Method for sequencing peptides or proteins
DE69420044D1 (de) Blutregulierende peptide
AU8184087A (en) Peptides which inhibit human plasma renin
EP0823056A4 (en) METHOD FOR CARBOXY-TERMINAL PROTEIN OR PEPTIDE SEQUENCING